Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Czech Republic
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Cyprus
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Switzerland
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Bulgaria
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Belgium
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Bosnia and Herzegovina
04030912.2
Filed on 2004-12-28
04030912.2
Filed on 2004-12-28
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Austria
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Albania
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
USE OF HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM METASTASES
Patent Cooperation Treaty
PCT/US2008/055149
Filed on 2008-02-27
PCT/US2008/055149
Filed on 2008-02-27
Triapine-induced Tumor Cell Radiosensitization
US Application 11/992,002
Filed on 2009-08-13
Filed on 2009-08-13